191个国家减少贫血的成本效益目标:一项建模研究
该建模研究构建国家层面卫生经济模型,基于成本效益分析为191个签约国设定育龄女性(15-49岁)贫血减少目标。结果显示,到2030年雄心勃勃、可实现且具成本效益的全球目标为减少17%(95%不确定性区间5-34),去除所有成本约束后最大可实现目标为减少22%(11-36),没有任何情景接近当前全球可持续发展目标50%的减少目标。
要点
- 到2030年育龄女性贫血减少的全球成本效益目标为17%(95%UI 5-34)。
- 去除所有成本约束后最大可实现目标为减少22%(11-36)。
- 没有任何情景接近当前50%的全球可持续发展目标。
核心结论
- 基于价值的全球贫血减少目标将大幅低于现有国际承诺。
- 使用现有推荐干预措施和成本效益证据设定的价值目标可为进展提供更好激励,并提供更现实的人类发展预测。
研究设计与样本
- 建模研究,开发国家层面卫生经济模型,基于成本效益分析设定育龄女性(15-49岁)贫血减少目标,应用于191个签约国。
- 模型整合国家特异性贫血现患率、推荐干预措施的效果及当前与最大覆盖率、当地单位成本和国家特异性成本效益阈值估计,包括全球疾病负担数据和人口与健康调查项目数据。
- 干预措施在1倍人均国内生产总值国家成本效益阈值下应用以最大化健康收益,通过蒙特卡洛模拟和考虑替代阈值、成本约束及覆盖率的情景评估参数不确定性。
主要发现
- 到2030年育龄女性贫血减少的雄心勃勃、可实现且具成本效益的全球目标为17%(95%不确定性区间5-34)。
- 去除所有成本约束后最大可实现目标为减少22%(11-36)。
- 没有任何情景接近当前50%的全球可持续发展目标减少目标,表明该目标用现有推荐干预措施无法实现。
- 各国减少目标范围为0%至29%,地区间和收入组间及内部存在显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anaemia causes widespread health and economic harm. Current international targets for reducing anaemia in women of reproductive age, including the Sustainable Development Goal of halving prevalence by 2030, are unlikely to be met by any signatory country. This outcome suggests that current targets were grounded in aspiration rather than a systematic assessment of what is achievable given current recommended interventions and national health-care priorities. We propose a novel method of target setting for global health goals, with reducing anaemia in women of reproductive age as an example. METHODS: In this modelling study, we developed a country-level health economic model to support feasible and ambitious target-setting for anaemia for women of reproductive age (aged 15-49 years) based on cost-effectiveness analysis and applied it to 191 signatory countries. Our model integrated country-specific data on the current prevalence of anaemia, the effectiveness and current and maximal coverage of recommended interventions available to each country, the local unit costs of these interventions, and country-specific cost-effectiveness threshold estimates, including Global Burden of Disease data and data from the Demographic and Health Survey Program. Interventions were applied to maximise health gains subject to country-level cost-effectiveness thresholds at 1 × gross domestic product per capita. We assessed parameter uncertainty through Monte Carlo simulations and scenarios that considered alternative thresholds, constraints on cost, and coverage. FINDINGS: Our results indicate that an ambitious, achievable, and cost-effective global target for anaemia reduction in women aged 15-49 years by 2030 is 17% (95% uncertainty interval [UI] 5-34). The maximum achievable target removing all cost constraints is a 22% (11-36) reduction. No scenario approached the current 50% global Sustainable Development Goal reduction target, indicating that this goal is unachievable with existing recommended interventions. Reduction targets for individual countries ranged from 0% to 29%, with substantial variation both between and within regions and income groups. INTERPRETATION: Our findings suggest that a value-based global target for anaemia reduction will be substantially lower than the existing international commitment. Value-based targets using evidence from available interventions and cost-effectiveness for what is achievable given countries' differing contexts can provide better incentives for progress and offer more realistic forecasts of human development. FUNDING: Gates Foundation.
引用
- Blythe R, Carvalho N, Holloway-Brown J, et al. Cost-effective targets for anaemia reduction in 191 countries: a modelling study. Lancet Haematol. 2025. PMID: 40882648. doi:10.1016/S2352-3026(25)00168-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。